Import 75% Alcohol Antibacterial Wet Wipes — Buy in Bulk from Supplier in China

Winhealth Medical (suzhou) Technology Co., Ltd manufactures 75% alcohol antibacterial wet wipes using pharmaceutical-grade ethyl alcohol derived from corn fermentation, with the finished product formulated to meet FDA requirements for over-the-counter drug products. The wipes are constructed from 45 GSM non-woven fabric measuring 15 cm by 20 cm when unfolded, a size that provides adequate coverage for single-hand sanitising without excessive material waste. The 75% ethyl alcohol concentration aligns with WHO formulation guidelines for hand hygiene in healthcare settings, where concentrations between 60% and 85% ethanol demonstrate optimal efficacy against enveloped viruses and vegetative bacteria. Each soft pack contains 50 wipes with a resealable closure designed to maintain moisture content between openings.

The 45 GSM non-woven substrate specified by Winhealth Medical falls within the standard weight range for single-use alcohol wipes, where lower basis weights below 40 GSM tend to tear during vigorous wiping while weights above 60 GSM become uneconomical for high-volume dispensing. The use of corn-derived ethanol rather than synthetic isopropanol reflects a manufacturing choice that may appeal to buyers seeking bio-based ingredient sourcing, though both alcohol types achieve comparable antimicrobial efficacy when formulated at equivalent concentrations. The soft pack format with resealable adhesive tape or plastic lid closure is standard for retail and professional channels where portability matters, though it offers less protection against alcohol evaporation than rigid container formats over extended storage. The absence of added fragrance eliminates a common source of contact dermatitis and simplifies ingredient disclosure for regulatory submissions in fragrance-sensitive markets.

Target buyers include healthcare facility procurement departments, corporate wellness programmes, airline catering suppliers, and retail pharmacy chains seeking private-label hand sanitising products. The FDA-compliant drug product classification positions these wipes for import into the United States under OTC monograph regulations, though foreign establishment registration and listing are required. Industrial buyers should confirm whether Winhealth Medical holds valid FDA drug establishment registration and whether the facility operates under pharmaceutical GMP or medical device quality system standards. The 15 x 20 cm wipe dimension suits both hand sanitisation and small-surface disinfection, making the product versatile for environments where separate hand and surface protocols would create logistical complexity.

Winhealth Medical (suzhou) Technology Co., Ltd is based in Suzhou, Jiangsu Province, China, a region with established medical device and pharmaceutical manufacturing clusters supplying both domestic and export markets. The company holds an imported supplier tier and harbor trust tier on the platform, indicating verified business documentation though not independent product certification verification. The response rate is recorded at 0.00% with zero average response hours, which signals either a recently established listing, a marketing channel not prioritised by the sales team, or data collection issues, buyers should initiate contact early to assess communication reliability. The company name explicitly positions itself as a medical technology enterprise, suggesting intended focus on regulated healthcare products rather than commodity consumer goods, though this positioning requires verification through facility audits and certification records.

The listing asserts FDA compliance for the finished product but does not specify whether Winhealth Medical itself holds FDA drug establishment registration, or whether the claim refers to a contract manufacturing arrangement with a US-registered entity. No information is provided about facility scale, production capacity, number of production lines, or whether the company manufactures the non-woven substrate in-house or sources it from approved suppliers. The Suzhou location offers logistical advantages through proximity to Shanghai Port and Pudong International Airport, with established cold chain and dangerous goods handling infrastructure for alcohol-based product export. Buyers should request the company's business licence, medical device production licence if applicable, and any ISO 13485 or pharmaceutical GMP certification directly, as these documents determine eligibility for supply to regulated healthcare markets.